Market Overview

Cree Cuts Q4 Guidance, Shares Fall


Cree, Inc. (NASDAQ: CREE) cut fourth-quarter earnings per share guidance from 12-16 cents to 8-12 cents, compared to a 21 cent analyst estimate.

Cree also cut sales guidance from $263 million-$271 million to $245 million-$252 million, compared to a $282.35 million estimate.

Cree traded down 4 percent at $57 per share in Tuesday's pre-market session.

Related Links:

PolyOne Raises Q2 Guidance

Slack To IPO Through Direct Listing On June 20

Posted-In: News Guidance


Related Articles (CREE)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer

CymaBay Therapeutics Plummets 40% Following Liver Disease Data